Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease

Lupus

Volumn 20, Issue 5, 2011, Pages 473-484

  Liu, S D ^a   Lee, S ^a   Cava, A La ^a   Motran, C C ^b   Hahn, B H ^a   Miceli, M C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

systemic lupus erythematosus; T cells; tolerance suppression anergy

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; GALECTIN 1; IMMUNOGLOBULIN G; RECOMBINANT GALECTIN 1; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; IMMUNOMODULATION; LUPUS LIKE SYNDROME; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOANTIBODIES; DNA; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GALECTIN 1; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; MICE; MICE, 129 STRAIN; MICE, INBRED NZB; MICE, KNOCKOUT; PROTEINURIA; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; SPLEEN; T-LYMPHOCYTES;

EID: 79955672547     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310388444     Document Type: Article

References (61)

1. Hoffman RW, Takeda Y, Sharp GC, et al. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J Immunol. 1993 ; 151: 6460-6469 (Pubitemid 23340392)
2. Fenning S, Wolff-Vorbeck G, Hackl W, et al. T cell lines recognizing the 70-kD protein of U1 small nuclear ribonucleoprotein (U1snRNP). Clin Exp Immunol. 1995 ; 101: 408-413
3. Wolff-Vorbeck G, Hackl W, Fenning S, et al. Characterization of an HLA-DR4-restricted T cell clone recognizing a protein moiety of small nuclear ribonucleoproteins (UsnRNP). Clin Exp Immunol. 1994 ; 95: 378-384 (Pubitemid 24210177)
4. Tan EM, Fritzler MJ, McDougal JS, et al. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum. 1982 ; 25: 1003-1005 (Pubitemid 12047030)
5. Holyst M-M, Hoffman RW. U-Small nuclear ribonucleoprotein (RNP)-reactive autoantibodies: Diagnostic testing and clinical interpretation. Clinical Immunology Newsletter. 1998 ; 18: 53-57
6. Greidinger EL, Hoffman RW. Antinuclear antibody testing: Methods, indications, and interpretation. Laboratory Medicine. 2003 ; 34: 113-117 (Pubitemid 36254968)
7. Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology (Oxford). 2005 ; 44: 975-982 (Pubitemid 41487168)
8. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985 ; 314: 537-539 (Pubitemid 15124262)
9. Hoffman RW. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 2004 ; 113: 4-13 (Pubitemid 39468261)
10. Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 1977 ; 20: 819-824
11. La Cava A, Fang CJ, Singh RP, et al. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev. 2005 ; 4: 515-519 (Pubitemid 41415762)
12. Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?. Trends Immunol. 2002 ; 23: 313-320 (Pubitemid 34628775)
13. Rabinovich GA, Liu FT, Hirashima M, Anderson A. An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol. 2007 ; 66: 143-158 (Pubitemid 47063211)
14. Cho M, Cummings RD. Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization. J Biol Chem. 1995 ; 270: 5198-5206
15. Gitt MA, Barondes SH. Genomic sequence and organization of two members of a human lectin gene family. Biochemistry. 1991 ; 30: 82-89
16. Hirabayashi J, Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993 ; 3: 297-304 (Pubitemid 23281277)
17. Kopitz J, von Reitzenstein C, Burchert M, et al. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem. 1998 ; 273: 11205-11211 (Pubitemid 28204971)
18. Pace KE, Hahn HP, Pang M, et al. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol. 2000 ; 165: 2331-2334 (Pubitemid 30660673)
19. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol. 1999 ; 163: 3801-3811 (Pubitemid 29450905)
20. Rappl G, Abken H, Muche JM, et al. CD4+CD7- leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia. 2002 ; 16: 840-845 (Pubitemid 34537556)
21. Blaser C, Kaufmann M, Müller C, et al. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol. 1998 ; 28: 2311-2319 (Pubitemid 28362706)
22. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature. 1995 ; 378: 736-739 (Pubitemid 126647279)
23. Motran C, Molinder K, Liu S, et al. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur J Immunol. 2008 ; 38: 3015-3027
24. Santucci L, Fiorucci S, Rubinstein N, et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology. 2003 ; 24: 1381-1394 (Pubitemid 36531812)
25. Baum LG, Blackall DP, Arias-Magallano S, et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol. 2003 ; 109: 295-307 (Pubitemid 38091450)
26. Santucci L, Fiorucci S, Cammilleri F, et al. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology. 2000 ; 31: 399-406 (Pubitemid 30078605)
27. Rabinovich GA, Daly G, Dreja H, et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med. 1999 ; 190: 385-398
28. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains [see comments]. Science. 1999 ; 283: 680-682
29. Chung CD, Patel VP, Moran M, et al. Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol. 2000 ; 165: 3722-3729 (Pubitemid 32057278)
30. Singh RR, Kumar V, Ebling FM, et al. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J Exp Med. 1995 ; 181: 2017-2027
31. Singh RR, Ebling FM, Albuquerque DA, et al. Induction of autoantibody production is limited in nonautoimmune mice. J Immunol. 2002 ; 169: 587-594 (Pubitemid 34686183)
32. Helyer BJ, Howie JB. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature. 1963 ; 197: 197-197
33. Vyse TJ, Kotzin BL. Genetic susceptibility to systemic lupus erythematosus. Ann Rev Immunol. 1998 ; 16: 261-292 (Pubitemid 28183366)
34. Vespa GN, Lewis LA, Kozak KR, et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol. 1999 ; 162: 799-806 (Pubitemid 29035402)
35. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998 ; 188: 287-296 (Pubitemid 28357757)
36. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus. 2008 ; 17: 421-425 (Pubitemid 351798720)
37. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995 ; 155: 1151-1164
38. Chen Y, Cuda C, Morel L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J Immunol. 2005 ; 174: 7692-7702 (Pubitemid 40806274)
39. Garin MI, Chu C-C, Golshayan D, et al. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood. 2007 ; 109: 2058-2065 (Pubitemid 46348206)
40. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002 ; 16: 311-323 (Pubitemid 34211969)
41. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003 ; 4: 330-336 (Pubitemid 36432314)
42. Zielinski CE, Jacob SN, Bouzahzah F, et al. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation. J Immunol. 2005 ; 174: 5100-5109
43. Toscano MA, Bianco GA, Ilarregui JM, et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 2007 ; 8: 825-834 (Pubitemid 47099035)
44. Poirier F, Robertson EJ. Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development. 1993 ; 119: 1229-1236 (Pubitemid 23358589)
45. Rabinovich GA, Iglesias MM, Modesti NM, et al. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J Immunol. 1998 ; 160: 4831-4840 (Pubitemid 28215317)
46. Massardo L, Metz C, Pardo E, et al. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus. 2009 ; 18: 539-546
47. Pardo E, Carcamo C, Massardo L, et al. [Antibodies against galectin-8 in patients with systemic lupus erythematosus]. Rev Med Chil. 2006 ; 134: 159-166 (Pubitemid 43429513)
48. Tribulatti MV, Mucci J, Cattaneo V, et al. Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation. Glycobiology. 2007 ; 17: 1404-1412 (Pubitemid 350131316)
49. Eshkar Sebban L, Ronen D, Levartovsky D, et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol. 2007 ; 179: 1225-1235
50. Niwa H, Satoh T, Matsushima Y, et al. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin Immunol. 2009 ; 132: 184-194
51. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005 ; 6: 1245-1252 (Pubitemid 43045636)
52. Wang Y, Meng J, Wang X, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol. 2008 ; 67: 63-70 (Pubitemid 350209587)
53. Pan HF, Ye DQ, Li XP. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2008 ; 4: 352-353 (Pubitemid 351974005)
54. Krishnan S, Nambiar MP, Warke VG, et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J Immunol. 2004 ; 172: 7821-7831 (Pubitemid 38747650)
55. Liossis S-NC, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest. 1998 ; 101: 1448-1457 (Pubitemid 28166843)
56. Jury EC, Kabouridis PS, Flores-Borja F, et al. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 2004 ; 113: 1176-1187 (Pubitemid 38544103)
57. Tenbrock K, Juang YT, Kyttaris VC, Tsokos GC. Altered signal transduction in SLE T cells. Rheumatology (Oxford). 2007 ; 46: 1525-1530 (Pubitemid 47500564)
58. Liu SD, Whiting CC, Tomassian T, et al. Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood. 2008 ; 112: 120-130
59. Akahoshi M, Nakashima H, Tanaka Y, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 1644-1648 (Pubitemid 30263632)
60. Chan RW, Lai FM, Li EK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford). 2006 ; 45: 951-957 (Pubitemid 44283048)
61. Xie C, Sharma R, Wang H, et al. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol. 2004 ; 172: 5047-5055 (Pubitemid 38456432)